Credits Available: 4.25 AMA PRA Category 1 Credits™, 4.25 ANCC Contact Hours, 4.25 ACPE

Description: This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell treatment; and the delivery of goal-concordant care using shared decision-making strategies. A challenging real-world case scenario discussion within each Gather-ed group highlights critical decision points, key challenges, and opportunities to incorporate collective insights.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Pharmacist, Physician Assistant, Nurse, Pharmacy Director
Target Specialties: Hematology, Hematology/Oncology, Oncology
Group Leader
Dr. Christin DeStefano is a triple-board certified hematologist/oncologist, Hematology/Oncology Division Director for the Department of Medicine at USU, Hematology/Oncology Fellowship Program Director at Walter Reed National Military Medical Center, and Hematology/Oncology Consultant to the Air Force Surgeon General. Her research interests deal with lymphoid and myeloid malignancies, immunodeficiency, and cancer epidemiology in military members.

 

Group Co-Leader

Maneesh Jain

George Washington University
Associate Professor of Medicine (George Washington University)

Physician at the VA and George Washington University. I enjoy treating GU malignancy and other solid tumors. Work closely with fellows.